Trials / Unknown
UnknownNCT02590510
Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Hui Bu · Academic / Other
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to compare the effect of 10 mg and 15 mg methotrexate in the treatment of meningeal carcinomatosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | methotrexate | The quantity of methotrexate is different in the two groups. |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-10-01
- First posted
- 2015-10-29
- Last updated
- 2016-10-28
Source: ClinicalTrials.gov record NCT02590510. Inclusion in this directory is not an endorsement.